Enlivex Therapeutics Statistics

Total Valuation

ENLV has a market cap or net worth of $20.89 million. The enterprise value is -$4.21 million.

Market Cap	20.89M
Enterprise Value	-4.21M

Important Dates

The next estimated earnings date is Tuesday, December 3, 2024, after market close.

Earnings Date	Dec 3, 2024
Ex-Dividend Date	n/a

Share Statistics

ENLV has 21.41 million shares outstanding. The number of shares has increased by 2.08% in one year.

Current Share Class	21.41M
Shares Outstanding	21.41M
Shares Change (YoY)	+2.08%
Shares Change (QoQ)	+4.37%
Owned by Insiders (%)	5.76%
Owned by Institutions (%)	3.27%
Float	15.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.71
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.06, with a Debt / Equity ratio of 0.03.

Current Ratio	10.06
Quick Ratio	9.57
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.17% and return on invested capital (ROIC) is -29.86%.

Return on Equity (ROE)	-61.17%
Return on Assets (ROA)	-27.46%
Return on Capital (ROIC)	-29.86%
Revenue Per Employee	n/a
Profits Per Employee	-$314,000
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.91% in the last 52 weeks. The beta is 1.10, so ENLV's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-43.91%
50-Day Moving Average	1.43
200-Day Moving Average	1.87
Relative Strength Index (RSI)	19.07
Average Volume (20 Days)	170,484

Short Selling Information

Short Interest	160,140
Short Previous Month	100,865
Short % of Shares Out	0.79%
Short % of Float	n/a
Short Ratio (days to cover)	1.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-18.66M
Pretax Income	-25.99M
Net Income	-22.29M
EBITDA	-17.89M
EBIT	-18.66M
Earnings Per Share (EPS)	-$1.18

Full Income Statement

Balance Sheet

The company has $25.94 million in cash and $835,000 in debt, giving a net cash position of $25.11 million or $1.17 per share.

Cash & Cash Equivalents	25.94M
Total Debt	835,000
Net Cash	25.11M
Net Cash Per Share	$1.17
Equity (Book Value)	28.56M
Book Value Per Share	1.37
Working Capital	25.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.02 million and capital expenditures -$95,000, giving a free cash flow of -$17.12 million.

Operating Cash Flow	-17.02M
Capital Expenditures	-95,000
Free Cash Flow	-17.12M
FCF Per Share	-$0.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.08%
Shareholder Yield	-2.08%
Earnings Yield	-106.71%
FCF Yield	-81.93%

Analyst Forecast

The average price target for ENLV is $9.50, which is 873.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	873.36%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2